Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
Loading...
Publication date
Advisors
Research group
Center
Abstract
The formation of calixarene-based liposomes was investigated, and the characterization of
these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were
used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the
polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed
with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine,
DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results
obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC12)4
, were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that
(TEAC12)4/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material,
although the transfection efficiency substantially increases in the presence of an additional amount of
DOPE as coadjuvant. On the other hand, the (TEAC12)4/DOPE liposomes present a high doxorubicin
encapsulation efficiency, and a slow controlled release, which could diminish the side effects of
the drug
Unesco Subjects
Bibliographic citation
Lebrón, J. A., López-López, M., García-Calderón, C. B., V. Rosado, I., Balestra, F. R., Huertas, P., Rodik, R. V., Kalchenko, V. I., Bernal, E., Moyá, M. L., López-Cornejo, P., & Ostos, F. J. (2021). Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery. In Pharmaceutics (Vol. 13, Issue 8, p. 1250). MDPI AG. https://doi.org/10.3390/pharmaceutics13081250













